Beijing-based AI-native peptide drug discovery company combining a large peptide dataset, generative and mirror-image peptide models, computational design, mirror-protein chemistry, and rapid design-synthesis experiments
Beijing-based AI-native peptide drug discovery company combining a large peptide dataset, generative and mirror-image peptide models, computational design, mirror-protein chemistry, and rapid design-synthesis experiments. It is developing partnerships and an in-house pipeline for oncology, autoimmune, and metabolic diseases.